From MarketBeat:

Xenon Pharmaceuticals Inc. received an increase of 2,362% in put options trading on Wednesday, with 4,063 put options bought compared to the average of 165. Insider Gary Patou sold 11,380 shares for $39.29 each, totaling $447,120.20. Hedge funds Manager and director involvement also disclosed. (111 words)

Xenon Pharmaceuticals opened at $46.46 on Thursday, with a 50-day moving average of $35.07. With a market capitalization of $3.04 billion and $27.99 as its 52-week low, the company anticipates posting -2.85 EPS for the year. Analysts have a “Moderate Buy” rating and an average target price of $56.29. (51 words)



Read more: Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)